Nov. 25-26th 2019 – Meet ReaGenics at CannaTech in CAPTOWN
CannaTech global cannabis events are widely recognized as as the industry’s premier experience for education, networking...
25 November, 2019
Contact
Problems with traditional cannabis cultivation
Expensive
Cost of machinery, facility, electricity, etc.
Difficult
Requires skilled workers
Time consuming
Whole plants take 6-12 weeks to flower
Unscalable
Yields are limited
Environmentally unsustainable
Uses large amounts of space and natural resources
Uncontrolled
Variations and contaminations in the environment make plants impossible to standardize
What’s the Solution?
Control all environmental factors by growing cannabis in a plant cell bio-reactor (PCBR)
About Our Technology
ReaGenics is pioneering a novel plant cell bioreactor process for the mass-scale multiplication of cannabinoids. This eliminates the need to grow plants on an industrial scale for pharma-grade, botanically- derived cannabinoids. Leveraging success with patented technology for multiplication and manipulation of lavender cells, ReaGenics is applying the same technology to cannabis, allowing for consistent, controllable, and patentable formulations.
ReaGenics anticipates production periods up to four times faster and projected costs considerably cheaper, than plant cultivation. Creating powdered biomass for active pharmaceutical ingredients or extracted to produce cannabinoid oils, Bio-Reactor Production will change the way we look at medical cannabis.
Contact Us To Learn More:
About the team
ReaGenics is an Israeli based company, with founders from Poland and Israel, bringing the best IP to the most dynamic cannabis ecosystem.
Dr. Michael Kagan – CEO and co-founder of ReaGenics. Serial entrepreneur with 12 patents and 15 years experience growing micro-algae in bioreactors, clinical trials and FDA approvals.
Rafal Slusarczyk – VP R&D and co-founder of ReaGenics. Biologist specializing in environmental science with 10 years of experience as a technology transfer expert.
Prof. Danuta Kulpa – Chief Scientist – Professor at the West Pomeranian University of Technology, Szczecin, Poland specializing in plant genetics, plant breeding and biotechnology.
Saul Kaye – Co-founder and Chief Advisor – Pharmacist, angel investor, serial entrepreneur, cannabis expert.
Product Pipeline:
– 80% CBD Broad Spectrum Hemp extract
– Full spectrum Cannabis extract – high THC, low CBD
– Rare cannabinoids (e.g. THCV, CBG)
– Unique, cannabinoid-based formulation for Irritable Bowel Disease, developed in collaboration with The Hebrew University of Jerusalem
Award Winning!
Co-founder, Rafal Slusarczyk, won sponsorship from the European Union as a participant in the Erasmus for Young Entrepreneurs program. He is the first member of the program in Israel.
We are always on the lookout for investors and collaborators.
Blog
We invite you to read the latest information on current events .
-
-
ReaGenics CEO Presents to NYC Investors – Sept. 12th 2019
Sept. 12th, NEW YORK – ReaGenics is proud to have presented at iCAN’s first-ever Israeli Cannabis Investor Symposium in ...
25 November, 2019 -
ReaGenics participates at CannaTech 2019 in Tel Aviv!
ReaGenics is thrilled to meet you on 1-2 April 2019 in Tel Aviv. We will have our boot with iCAN incubator. CannaTech is...
28 March, 2019
Contact
Contact us to discover opportunities!
ReaGenics
SUBS hub, 5 Hauman Street
Beit Shemesh, Israel
Tel. +972 54 4405207